| Chimeric antigen receptor T cells for sustained remissions in leukemia SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ... New England Journal of Medicine 371 (16), 1507-1517, 2014 | 6146 | 2014 |
| Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia DL Porter, WT Hwang, NV Frey, SF Lacey, PA Shaw, AW Loren, A Bagg, ... Science translational medicine 7 (303), 303ra139-303ra139, 2015 | 1973 | 2015 |
| Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia DT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ... Cancer discovery 6 (6), 664-679, 2016 | 1098 | 2016 |
| GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity MA Spinner, LA Sanchez, AP Hsu, PA Shaw, CS Zerbe, KR Calvo, ... Blood, The Journal of the American Society of Hematology 123 (6), 809-821, 2014 | 755 | 2014 |
| Linezolid for treatment of chronic extensively drug-resistant tuberculosis M Lee, J Lee, MW Carroll, H Choi, S Min, T Song, LE Via, LC Goldfeder, ... New England Journal of Medicine 367 (16), 1508-1518, 2012 | 737 | 2012 |
| Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems DR Prevots, PA Shaw, D Strickland, LA Jackson, MA Raebel, MA Blosky, ... American journal of respiratory and critical care medicine 182 (7), 970-976, 2010 | 664 | 2010 |
| Adult-onset immunodeficiency in Thailand and Taiwan SK Browne, PD Burbelo, P Chetchotisakd, Y Suputtamongkol, ... New England Journal of Medicine 367 (8), 725-734, 2012 | 547 | 2012 |
| Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia JC Fitzgerald, SL Weiss, SL Maude, DM Barrett, SF Lacey, JJ Melenhorst, ... Critical care medicine 45 (2), e124-e131, 2017 | 485 | 2017 |
| Exact and asymptotic weighted logrank tests for interval censored data: the interval R package MP Fay, PA Shaw Journal of statistical software 36 (1), 1-34, 2010 | 474 | 2010 |
| Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative ML Neuhouser, L Tinker, PA Shaw, D Schoeller, SA Bingham, LV Horn, ... American journal of epidemiology 167 (10), 1247-1259, 2008 | 388 | 2008 |
| D614G spike mutation increases SARS CoV-2 susceptibility to neutralization D Weissman, MG Alameh, T de Silva, P Collini, H Hornsby, R Brown, ... Cell host & microbe 29 (1), 23-31. e4, 2021 | 380 | 2021 |
| Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model MJ Memoli, PA Shaw, A Han, L Czajkowski, S Reed, R Athota, T Bristol, ... MBio 7 (2), 10.1128/mbio. 00417-16, 2016 | 345 | 2016 |
| Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program BB Poindexter, R Feng, B Schmidt, JL Aschner, RA Ballard, A Hamvas, ... Annals of the American Thoracic Society 12 (12), 1822-1830, 2015 | 264 | 2015 |
| Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors DI Zonios, J Falloon, JE Bennett, PA Shaw, D Chaitt, MW Baseler, ... Blood, The Journal of the American Society of Hematology 112 (2), 287-294, 2008 | 259 | 2008 |
| Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations S Price, PA Shaw, A Seitz, G Joshi, J Davis, JE Niemela, K Perkins, ... Blood, The Journal of the American Society of Hematology 123 (13), 1989-1999, 2014 | 252 | 2014 |
| Optimizing chimeric antigen receptor T-cell therapy for adults with acute lymphoblastic leukemia NV Frey, PA Shaw, EO Hexner, E Pequignot, S Gill, SM Luger, ... Journal of Clinical Oncology 38 (5), 415-422, 2020 | 235 | 2020 |
| Thyroid dysfunction in heart failure and cardiovascular outcomes L Kannan, PA Shaw, MP Morley, J Brandimarto, JC Fang, NK Sweitzer, ... Circulation: Heart Failure 11 (12), e005266, 2018 | 214 | 2018 |
| Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial RD Etzioni, N Howlader, PA Shaw, DP Ankerst, DF Penson, PJ Goodman, ... The Journal of urology 174 (3), 877-881, 2005 | 192 | 2005 |
| Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease KN Olivier, PA Shaw, TS Glaser, D Bhattacharyya, M Fleshner, CC Brewer, ... Annals of the American Thoracic Society 11 (1), 30-35, 2014 | 189 | 2014 |
| Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL. SL Maude, DT Teachey, SR Rheingold, PA Shaw, R Aplenc, DM Barrett, ... Journal of Clinical Oncology 34 (15_suppl), 3011-3011, 2016 | 181 | 2016 |
Stephan A. GruppProfessor of Pediatrics, University of Pennsylvania School of MedicineZweryfikowany adres z chop.edu
